Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi Awaiting Key Meeting With FDA To Recommence Cialis Switch

Feb 05 2024

• By Tom Gallen

• Source: Shutterstock

Related Content

Delay For Sanofi’s OTC Cialis Study In US Could Be Sign of Hurdles Holding Back Other Switches

May 31 2022

Sanofi Starting US Cialis OTC Actual Use Study Soon While Tamiflu Switch Progress Delayed

Apr 29 2022

Sanofi Counts On OTC Switches Adding $1bn In Consumer Revenues By 2026

Dec 12 2019

Sanofi Consumer Healthcare Separation: Four Talking Points

Nov 08 2023

Sanofi Takes The Plunge With Consumer Health Separation After Years Laying Groundwork

Oct 27 2023

Sanofi Grows In US With Healthy Aging VMS Brand Qunol

Jul 31 2023

Additional Topics

Europe International United States Prescription To OTC Switch Sales & Earnings Business Strategies Dietary Supplements OTC Drugs Consumer

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window